Artificial oxygen carriers: a current review.

摘要: Artificial oxygen carriers are not blood substitutes. They serve to carry tissues and either hemoglobin based or perfluorocarbon based. Driving the development of artificial concerns involving both safety quantity supply. No currently approved for clinical use in United States. Hemopure has been South Africa. The companies producing PolyHeme, which hemoglobin-based carriers, have filed a Biologic License Application Phase III trials completed Hemopure, while PolyHeme is undergoing phase Urban Ambulance Trial. North American under way perfluorocarbons.